BOUT:NYE-Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 35.08

Change

0.00 (0.00)%

Market Cap

USD 0.01B

Volume

4.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-01 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+1.50 (+1.12%)

USD 18.06B
VOT Vanguard Mid-Cap Growth Index ..

+2.90 (+1.07%)

USD 15.90B
IJK iShares S&P Mid-Cap 400 Growth..

+1.06 (+1.20%)

USD 8.83B
XMMO Invesco S&P MidCap Momentum ET..

+1.14 (+0.91%)

USD 3.81B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+1.37 (+1.25%)

USD 1.08B
CWS AdvisorShares Focused Equity E..

+0.42 (+0.61%)

USD 0.18B
ETHO Amplify ETF Trust

+0.85 (+1.51%)

USD 0.18B
BFOR Barron's 400 ETF

+0.71 (+0.95%)

USD 0.15B
IPO Renaissance IPO ETF

+0.22 (+0.50%)

USD 0.14B
PEXL Pacer US Export Leaders ETF

+0.69 (+1.43%)

USD 0.04B

ETFs Containing BOUT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.21% 6% D- 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.21% 6% D- 19% F
Trailing 12 Months  
Capital Gain -0.20% 44% F 42% F
Dividend Return 0.02% 8% B- N/A F
Total Return -0.19% 44% F 34% F
Trailing 5 Years  
Capital Gain 59.60% 61% D- 66% D+
Dividend Return 3.83% 44% F 8% B-
Total Return 63.43% 61% D- 58% F
Average Annual (5 Year Horizon)  
Capital Gain 8.48% 72% C 68% D+
Dividend Return 9.09% 72% C 63% D
Total Return 0.61% 50% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 19.42% 61% D- 50% F
Risk Adjusted Return 46.81% 72% C 64% D
Market Capitalization 0.01B 8% B- 7% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.